Table 1. Patient characteristics at baseline.

N	46
Dates of enrollment	Jan 2011 – Jan 2013
Age (median)	67 y.o. (range, 40-84)
ECOG performance status (0/1)	32/14 (70%/30%)
Stage (metastatic/locally advanced)	44/2 (96%/4%)
Prior chemotherapy
Gemcitabine-based	34 (74%)
FOLFIRINOX	10 (22%)
Other	2 (4%)
Prior surgery	14 (30%)
Prior radiation	7 (15%)
Elevated baseline CA19-9 > 2× ULN	34 (74%)